Comment on: Complement C3 and fatty liver disease in Rheumatoid arthritis patients: A cross-sectional study
Eur J Clin Invest
.
2018 Feb;48(2).
doi: 10.1111/eci.12879.
Epub 2018 Jan 8.
Authors
Fatemeh Khosravi Shadmani
1
,
Salman Khazaei
2
,
Shiva Mansouri Hanis
3
,
Kamyar Mansori
4
5
Affiliations
1
Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
2
Department of Epidemiology, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran.
3
School of Public Health, Dezful University of Medical Sciences, Dezful, Iran.
4
Social Determinants of Health Research Center, Kurdistan University of Medical Sciences, Sanandaj, Iran.
5
Department of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
PMID:
29266243
DOI:
10.1111/eci.12879
No abstract available
Publication types
Letter
Comment
MeSH terms
Arthritis, Rheumatoid*
Complement C3 / analysis*
Complement C4
Cross-Sectional Studies
Fatty Liver
Humans
Substances
Complement C3
Complement C4